J. Currie

发表

Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling

R. Béliveau, B. Annabi, S. Rabbani, 2006, Anti-cancer drugs.

ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice

J. Lachowicz, B. Annabi, M. Demeule, 2014, Molecular Cancer Therapeutics.

MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells

B. Annabi, J. Galipeau, Jian Cao, 2007, Journal of Biological Chemistry.

New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.

R. Béliveau, Gaoqiang Yang, M. Demeule, 2010, Journal of medicinal chemistry.

Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg.

R. Béliveau, B. Annabi, A. Moghrabi, 2007, Leukemia research.

Abstract 6362: TH1901, a novel curcumin-peptide conjugate for the treatment of Sortilin-positive (SORT1+) cancer

R. Béliveau, B. Annabi, M. Demeule, 2020 .

New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells

R. Béliveau, B. Annabi, M. Demeule, 2021, Frontiers in Oncology.

Transport characteristics of a novel peptide platform for CNS therapeutics

R. Béliveau, H. Sartelet, A. Abulrob, 2009, Journal of cellular and molecular medicine.

The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells

R. Béliveau, B. Annabi, M. Demeule, 2022, Pharmaceutics.

The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers

R. Béliveau, B. Annabi, M. Demeule, 2022, Cancers.

TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer

R. Béliveau, B. Annabi, M. Demeule, 2021, Cancer science.

Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1

R. Béliveau, H. Sartelet, A. Abulrob, 2011, British Journal of Cancer.

A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis

R. Béliveau, B. Annabi, S. Rabbani, 2005, Clinical & Experimental Metastasis.

Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.

R. Béliveau, B. Annabi, S. Rabbani, 2006, Biochemical and biophysical research communications.

Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells

B. Annabi, Jean-Christophe Currie, Anissa Belkaid, 2005, Cancer Cell International.

Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2

R. Béliveau, Tran Nguyen, M. Demeule, 2008, Journal of neurochemistry.

ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice

J. Lachowicz, B. Annabi, M. Demeule, 2014, Molecular Cancer Therapeutics.

Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing

B. Annabi, M. Demeule, Cyndia Charfi, 2024, Frontiers in immunology.